Long-acting GHRH analog often paired with Ipamorelin for GH optimization.
CJC-1295 is a longer-acting GHRH analog that increases GH and IGF-1 in a physiologic manner. Commonly paired with Ipamorelin (a GHRP) to amplify pulsatile release without the side-effect profile of older GHRPs.
Subcutaneous injection 2–5× weekly, typically at night. Effects build over weeks.
Extended half-life GHRH analog binds pituitary GHRH receptors — same physiology as Sermorelin with longer coverage.
Not indicated in active malignancy; IGF-1 monitoring recommended. Avoid with severe renal or hepatic disease.
This page is educational and not medical advice. All VitaFlow protocols require evaluation by a licensed Florida physician.
GHRH + GHRP produces a larger, cleaner GH pulse than either alone.
3–6 months on, then break.
Non-DAC CJC-1295 is preferred to maintain natural pulsatility.
Nighttime is standard.
GHRH analog that stimulates your body's own growth hormone in a physiologic pattern.
Selective GH secretagogue with minimal impact on cortisol, prolactin or appetite.
FDA-approved GHRH analog with strong evidence for visceral fat reduction.
Meet with a VitaFlow physician to design a protocol tailored to your goals, biomarkers, and lifestyle.
